SCHEMBL1675322

SCHEMBL1675322

c1nc(N2CCCCC2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK4 Q9HAZ1 12/20 0.78
CYP1A2 P05177 11/20 0.78
CYP3A4 P08684 11/20 0.78
CYP2D6 P10635 10/20 0.78
ALDH1A1 P00352 7/20 0.78
CYP2C19 P33261 6/20 0.78
LMNA P02545 6/20 0.78
MAPK1 P28482 5/20 0.78
USP2 O75604 5/20 0.78
HIF1A Q16665 4/20 0.78
MEN1 O00255 2/20 0.78
KMT2A Q03164 2/20 0.78
HSD17B10 Q99714 6/20 0.57
TSHR P16473 4/20 0.57
CLK1 P49759 5/20 0.55
CLK2 P49760 4/20 0.55
CLK3 P49761 4/20 0.55
DYRK1A Q13627 4/20 0.55
DYRK1B Q9Y463 4/20 0.55
HTT P42858 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1675378 0.89 CYP3A4 (0.77) CLK4CYP1A2CYP3A4CYP2D6ALDH1A1
SCHEMBL1675259 0.88 CYP1A2 (1.00) CLK4CYP1A2CYP3A4CYP2D6ALDH1A1
SCHEMBL1675346 0.88 CLK4 (0.68) CLK4CYP1A2CYP3A4CYP2D6ALDH1A1
SCHEMBL4361869 0.79 HTT (0.55) CLK4CYP1A2CYP3A4CYP2D6ALDH1A1
SCHEMBL4356019 0.79 HTT (0.55) CLK4CYP1A2CYP3A4CYP2D6ALDH1A1
SCHEMBL1675117 0.76 CLK4 (0.65) CLK4CYP1A2CYP3A4CYP2D6ALDH1A1
SCHEMBL4363770 0.75 GAK (0.64) CLK4CYP1A2CYP3A4CYP2D6ALDH1A1
SCHEMBL3852413 0.75 HTT (0.60) CLK4CYP1A2CYP3A4CYP2D6ALDH1A1
SCHEMBL3114664 0.74 CYP1A2 (0.54) CLK4CYP1A2CYP3A4CYP2D6ALDH1A1
SCHEMBL3852063 0.74 HTT (0.68) CLK4CYP1A2CYP3A4CYP2D6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO claimed
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO disclosed